Abstract
Rationale
Hyponatremia affects 10% of patients with chronic schizophrenia and can lead to severe consequences. However, the role of antipsychotics and other risk factors in hyponatremia occurrence has remained inconsistent.
Objective
This study examined the association between antipsychotic use and hyponatremia occurrence in patients with schizophrenia.
Methods
We utilized the National Health Insurance Research Database to follow 2051 patients with schizophrenia from 1998 to 2013. Among them, 137 (6.7%) developed hyponatremia. Sociodemographic characteristics, physical comorbidities, and psychiatric treatment experiences were compared between those who had hyponatremia and those who did not. A Cox proportional hazards model was used to examine the hazard ratios (HRs) of these characteristics.
Results
In patients with hyponatremia, the mean age at first hyponatremia occurrence was 54.7 ± 13.9 years, an average of 9.5 ± 4.0 years after schizophrenia diagnosis, and 32.9% of them were off antipsychotics before hyponatremia occurrences. Age at schizophrenia diagnosis (HR = 1.1), low-income household (HR = 2.4), comorbidities (HR = 1.2), and psychiatric admissions (HR = 1.04) were associated with the risks of hyponatremia. Compared with no antipsychotic use, atypical (HR = 2.1) and typical antipsychotics (HR = 3.1) were associated with an elevated risk of hyponatremia, after adjustment for age, sex, and physical comorbidities. Carbamazepine use (HR = 2.9) was also a significant risk factor for hyponatremia (p < 0.05).
Conclusions
Antipsychotic use in patients with schizophrenia with polypharmacy should be monitored for hyponatremia occurrences. Clinicians should pay attention to the impact of poor living conditions on hyponatremia occurrence.
Similar content being viewed by others
References
Ajlouni K, Kern MW, Tures JF, Theil GB, Hagen TC (1974) Thiothixene-induced hyponatremia. Arch Intern Med 134(6):1103–1105
Akkaya C, Sarandol A, Sivrioglu EY, Kotan Z, Kirli S (2006) A patient using ziprasidone with polydipsia, seizure, hyponatremia and rhabdomyolysis. Prog Neuro-Psychopharmacol Biol Psychiatry 30(8):1535–1538. doi:10.1016/j.pnpbp.2006.05.020
Atalay A, Turhan N, Aki OE (2007) A challenging case of syndrome of inappropriate secretion of antidiuretic hormone in an elderly patient secondary to quetiapine. South Med J 100(8):832–833
Atsariyasing W, Goldman MB (2014) A systematic review of the ability of urine concentration to distinguish antipsychotic- from psychosis-induced hyponatremia. Psychiatry Res. doi:10.1016/j.psychres.2014.03.021
Bachu K, Godkar D, Gasparyan A, Sircar P, Yakoby M, Niranjan S (2006) Aripiprazole-induced syndrome of inappropriate antidiuretic hormone secretion (SIADH). Am J Ther 13(4):370–372
Berghuis B, de Haan GJ, van den Broek MP, Sander JW, Lindhout D, Koeleman BP (2016) Epidemiology, pathophysiology and putative genetic basis of carbamazepine- and oxcarbazepine-induced hyponatremia. Eur J Neurol 23(9):1393–1399. doi:10.1111/ene.13069
Bersani G, Pesaresi L, Orlandi V, Gherardelli S, Pancheri P (2007) Atypical antipsychotics and polydipsia: a cause or a treatment? Hum Psychopharmacol 22(2):103–107. doi:10.1002/hup.825
Byatt CM, Millard PH, Levin GE (1990) Diuretics and electrolyte disturbances in 1000 consecutive geriatric admissions. J R Soc Med 83(11):704–708
Cadnapaphornchai MA, Summer SN, Falk S, Thurman JM, Knepper MA, Schrier RW (2003) Effect of primary polydipsia on aquaporin and sodium transporter abundance. Am J Physiol Renal Physiol 285(5):F965–F971. doi:10.1152/ajprenal.00085.2003
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383
Clayton JA, Le Jeune IR, Hall IP (2006) Severe hyponatraemia in medical in-patients: aetiology, assessment and outcome. QJM 99(8):505–511. doi:10.1093/qjmed/hcl071
de Leon J (2003) Polydipsia—a study in a long-term psychiatric unit. Eur Arch Psychiatry Clin Neurosci 253(1):37–39. doi:10.1007/s00406-003-0403-z
de Leon J, Dadvand M, Canuso C, Odom-White A, Stanilla J, Simpson GM (1996) Polydipsia and water intoxication in a long-term psychiatric hospital. Biol Psychiatry 40(1):28–34. doi:10.1016/0006-3223(95)00353-3
de Leon J, Tracy J, McCann E, McGrory A (2002) Polydipsia and schizophrenia in a psychiatric hospital: a replication study. Schizophr Res 57(2–3):293–301
de Leon J, Verghese C, Stanilla JK, Lawrence T, Simpson GM (1995) Treatment of polydipsia and hyponatremia in psychiatric patients. Can clozapine be a new option? Neuropsychopharmacology 12(2):133–138. doi:10.1016/0893-133X(94)00069-C
de Leon J, Verghese C, Tracy JI, Josiassen RC, Simpson GM (1994) Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biol Psychiatry 35(6):408–419
De Picker L, Van Den Eede F, Dumont G, Moorkens G, Sabbe BG (2014) Antidepressants and the risk of hyponatremia: a class-by-class review of literature. Psychosomatics 55(6):536–547. doi:10.1016/j.psym.2014.01.010
Funayama M, Hisamatsu T, Koreki A (2011) Central pontine demyelinolysis following water intoxication in schizophrenia. Schizophr Res 125(2–3):300–301. doi:10.1016/j.schres.2010.07.009
Goldman MB, Luchins DJ, Robertson GL (1988) Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia. N Engl J Med 318(7):397–403. doi:10.1056/NEJM198802183180702
Goldman MB, Robertson GL, Luchins DJ, Hedeker D (1996) The influence of polydipsia on water excretion in hyponatremic, polydipsic, schizophrenic patients. J Clin Endocrinol Metab 81(4):1465–1470. doi:10.1210/jcem.81.4.8636352
Goldman MB, Robertson GL, Luchins DJ, Hedeker D, Pandey GN (1997) Psychotic exacerbations and enhanced vasopressin secretion in schizophrenic patients with hyponatremia and polydipsia. Arch Gen Psychiatry 54(5):443–449
Grikiniene J, Volbekas V, Stakisaitis D (2004) Gender differences of sodium metabolism and hyponatremia as an adverse drug effect. Medicina (Kaunas) 40(10):935–942
Hariprasad MK, Eisinger RP, Nadler IM, Padmanabhan CS, Nidus BD (1980) Hyponatremia in psychogenic polydipsia. Arch Intern Med 140(12):1639–1642
Illowsky BP, Kirch DG (1988) Polydipsia and hyponatremia in psychiatric patients. Am J Psychiatry 145(6):675–683. doi:10.1176/ajp.145.6.675
Jos CJ, Evenson RC, Mallya AR (1986) Self-induced water intoxication: a comparison of 34 cases with matched controls. J Clin Psychiatry 47(7):368–370
Kimelman N, Albert SG (1984) Phenothiazine-induced hyponatremia in the elderly. Gerontology 30(2):132–136
Kirby D, Ames D (2001) Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients. Int J Geriatr Psychiatry 16(5):484–493
Kohen I, Voelker S, Manu P (2008) Antipsychotic-induced hyponatremia: case report and literature review. Am J Ther 15(5):492–494. doi:10.1097/MJT.0b013e31817276e9
Lane RM (1997) SSRIs and hyponatraemia. Br J Clin Pract 51(3):144–146
Lange-Asschenfeldt C, Kojda G, Cordes J, Hellen F, Gillmann A, Grohmann R, Supprian T (2013) Epidemiology, symptoms, and treatment characteristics of hyponatremic psychiatric inpatients. J Clin Psychopharmacol 33(6):799–805. doi:10.1097/JCP.0b013e3182a4736f
Lin GM, Chen YJ, Kuo DJ, Jaiteh LE, Wu YC, Lo TS, Li YH (2013) Cancer incidence in patients with schizophrenia or bipolar disorder: a nationwide population-based study in Taiwan, 1997–2009. Schizophr Bull 39(2):407–416. doi:10.1093/schbul/sbr162
Lin KB, Chan CL, Yang NP, Lai RK, Liu YH, Zhu SZ, Pan RH (2015) Epidemiology of appendicitis and appendectomy for the low-income population in Taiwan, 2003–2011. BMC Gastroenterol 1518. doi:10.1186/s12876-015-0242-1
Lydakis C, Apostolakis S, Thalassinos E, Stamataki K, Saridaki K, Basta M (2005) PIP syndrome: a potentially threatening manifestation of a psychiatric disorder. Int J Clin Pract 59(5):612–613. doi:10.1111/j.1368-5031.2005.00532.x
Mannesse CK, van Puijenbroek EP, Jansen PA, van Marum RJ, Souverein PC, Egberts TC (2010) Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase. Drug Saf 33(7):569–578. doi:10.2165/11532560-000000000-00000
Martin DJ, Park J, Langan J, Connolly M, Smith DJ, Taylor M (2014a) Socioeconomic status and prescribing for schizophrenia: analysis of 3200 cases from the Glasgow Psychosis Clinical Information System (PsyCIS). Psychiatr Bull 38(2):54–57. doi:10.1192/pb.bp.112.042143
Martin JL, McLean G, Park J, Martin DJ, Connolly M, Mercer SW, Smith DJ (2014b) Impact of socioeconomic deprivation on rate and cause of death in severe mental illness. BMC Psychiatry 14261. doi:10.1186/s12888-014-0261-4
Meulendijks D, Mannesse CK, Jansen PA, van Marum RJ, Egberts TC (2010) Antipsychotic-induced hyponatraemia: a systematic review of the published evidence. Drug Saf 33(2):101–114. doi:10.2165/11319070-000000000-00000
Muller RJ, Lann HD (1991) Thiazide diuretics and polydipsia in schizophrenic patients. Am J Psychiatry 148(3):390
Ogilvie AD, Croy MF (1992) Clozapine and hyponatraemia. Lancet 340(8820):672
Pavalonis D, Shutty M, Hundley P, Leadbetter R, Vieweg V, Downs M (1992) Behavioral intervention to reduce water intake in the syndrome of psychosis, intermittent hyponatremia, and polydipsia. J Behav Ther Exp Psychiatry 23(1):51–57
Peck V, Shenkman L (1979) Haloperidol-induced syndrome of inappropriate secretion of antidiuretic hormone. Clin Pharmacol Ther 26(4):442–444
Romano PS, Roos LL, Jollis JG (1993) Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 46(10):1075–1079 discussion 1081-1090
Shah PJ, Greenberg WM (1991) Water intoxication precipitated by thiazide diuretics in polydipsic psychiatric patients. Am J Psychiatry 148(10):1424–1425. doi:10.1176/ajp.148.10.aj148101424
Shutty MS Jr, Briscoe L, Sautter S, Leadbetter RA (1993) Neuropsychological manifestations of hyponatremia in chronic schizophrenic patients with the syndrome of psychosis, intermittent hyponatremia and polydipsia (PIP). Schizophr Res 10(2):125–130
Spigset O, Hedenmalm K (1996) Hyponatremia during treatment with clomipramine, perphenazine, or clozapine: study of therapeutic drug monitoring samples. J Clin Psychopharmacol 16(5):412–414
Upadhyay A, Jaber BL, Madias NE (2006) Incidence and prevalence of hyponatremia. Am J Med 119(7 Suppl 1):S30–S35. doi:10.1016/j.amjmed.2006.05.005
van den Heuvel OA, Bet PM, van Dam EW, Eeckhout AM (2006) The syndrome of inappropriate antidiuretic hormone secretion (SIADH) during treatment with the antipsychotic agents haloperidol and quetiapine. Ned Tijdschr Geneeskd 150(35):1944–1948
Vieweg WV, Carey RM, Godleski LS, Tisdelle DA, Pruzinsky T, Yank GR (1990) The syndrome of psychosis, intermittent hyponatremia, and polydipsia: evidence for diurnal volume expansion. Psychiatr Med 8(4):135–144
Vieweg WV, Leadbetter RA (1997) Polydipsia-hyponatraemia syndrome: epidemiology, clinical features and treatment. CNS Drugs 7(2):121–138. doi:10.2165/00023210-199707020-00004
Whitten JR, Ruehter VL (1997) Risperidone and hyponatremia: a case report. Ann Clin Psychiatry 9(3):181–183
Wicki J, Rutschmann OT, Burri H, Vecchietti G, Desmeules J (1998) Rhabdomyolysis after correction of hyponatremia due to psychogenic polydipsia possibly complicated by clozapine. Ann Pharmacother 32(9):892–895
Williams ST, Kores RC (2011) Psychogenic polydipsia: comparison of a community sample with an institutionalized population. Psychiatry Res 187(1–2):310–311. doi:10.1016/j.psychres.2010.10.035
Wu CY, Chen YJ, Ho HJ, Hsu YC, Kuo KN, Wu MS, Lin JT (2012) Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA 308(18):1906–1914
Yam FK, Jackson EA, Kwan BK (2013) Syndrome of inappropriate antidiuretic hormone associated with aripiprazole. Am J Health Syst Pharm 70(23):2110–2114. doi:10.2146/ajhp130142
Zaidi AN (2005) Rhabdomyolysis after correction of hyponatremia in psychogenic polydipsia possibly complicated by ziprasidone. Ann Pharmacother 39(10):1726–1731
Acknowledgements
This study is based on data from the National Health Insurance Research Database provided by the National Health Insurance Administration, Ministry of Health and Welfare and managed by National Health Research Institutes (Registered number NHIRD-104-027). The interpretation and conclusions contained herein do not represent those of National Health Insurance Administration, Ministry of Health and Welfare or National Health Research Institutes.
This study was financially supported by China Medical University Hospital (DMR-104-075). The supporters had no role in the design, analysis, interpretation, or publication of this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was approved by the Institutional Review Board of China Medical University Hospital (CMUH103-REC2-154).
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Yang, HJ., Cheng, WJ. Antipsychotic use is a risk factor for hyponatremia in patients with schizophrenia: a 15-year follow-up study. Psychopharmacology 234, 869–876 (2017). https://doi.org/10.1007/s00213-017-4525-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-017-4525-9